Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population
- 1 February 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 10 (1) , 67-78
- https://doi.org/10.1097/00008571-200002000-00009
Abstract
A non-invasive urine analysis method to determine the in-vivo flavin-containing monooxygenase (FMO) activity catalysing N-oxidation of ranitidine (RA) was developed and used to phenotype a Korean population. FMO activity was assessed by the molar concentration ratio of RA and RANO in the bulked 8 h urine. This method was used to determine the FMO phenotypes of 210 Korean volunteers (173 men and 37 women, 110 nonsmokers and 100 smokers). Urinary RA/RANO ratio, representing the metabolic ratio and the reciprocal index of FMO activity, ranged from 5.67–27.20 (4.8-fold difference) and was not different between men and women (P = 0.76) or between smokers and nonsmokers (P = 0.50). The frequencies of RA/RANO ratios were distributed in a trimodal fashion. Among the 210 Korean subjects, 93 (44.3%) were fast metabolizers, 104 (49.5%) were intermediate metabolizers and 13 (6.2%) were slow metabolizers. Subsequently, the relationship between the ranitidine N-oxidation phenotypes and FMO3 genotypes, determined by the presence of two previously identified mutant alleles (Glu158Lys: FMO3/Lys158 and Glu308Gly: FMO3/Gly308 alleles) commonly found in our Korean population was examined. The results showed that subjects who were homozygous and heterozygous for either one or both of the FMO3/Lys158 and FMO3/Gly308 mutant alleles had significantly lower in-vivo FMO activities than those with homozygous wild-type alleles (FMO3/Glu158 and FMO3/Glu308) (P < 0.001, Mann–Whitney U-test). Furthermore, the FMO activities of subjects with either FMO3/Lys158 or FMO3/Gly308 mutant alleles were almost identical to those having both FMO3 mutant alleles (FMO3/Lys158 and FMO3/Gly308). These two mutant alleles located, respectively, at exons 4 and 7 in the FMO3 gene appeared to be strongly linked by cis-configuration in Koreans. Therefore, we concluded that presence of FMO3/Lys158 and FMO3/Gly308 mutant alleles in FMO3 gene is responsible for the low ranitidine N-oxidation (FMO3 activity) in our Korean population.Keywords
This publication has 18 references indexed in Scilit:
- Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndromeNature Genetics, 1997
- Human Flavin-Containing Monooxygenase Form 3: cDNA Expression of the Enzymes Containing Amino Acid Substitutions Observed in Individuals with TrimethylaminuriaChemical Research in Toxicology, 1997
- Oxidation of Caffeine to Theobromine and Theophylline Is Catalyzed Primarily by Flavin-Containing Monooxygenase in Liver MicrosomesBiochemical and Biophysical Research Communications, 1997
- Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4European Journal of Biochemistry, 1996
- Structural and Catalytic Properties of the Mammalian Flavin-Containing MonooxygenaseChemical Research in Toxicology, 1995
- The Mammalian Flavin-Containing Monooxygenases: Molecular Characterization and Regulation of ExpressionToxicology and Applied Pharmacology, 1994
- The fish odour syndrome: biochemical, familial, and clinical aspects.BMJ, 1993
- A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot.Published by Wiley ,1991
- Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- URINARY EXCRETION OF CHOLINE METABOLITES FOLLOWING CHOLINE ADMINISTRATION IN NORMALS AND PATIENTS WITH HEPATOBILIARY DISEASES 1Journal of Clinical Investigation, 1951